Login / Signup

Comparison of short- and long-term adverse kidney outcomes after chimeric antigen receptor T cell therapy and autologous hematopoietic stem cell transplant for diffuse large B cell lymphoma.

Paul HannaIan StrohbehnDaiana MorenoDestiny HardenHarish SeethapathyShruti GuptaMeghan LeeTianqi OuyangMatthew FrigaultMeghan E Sise
Published in: Bone marrow transplantation (2022)
Keyphrases
  • diffuse large b cell lymphoma
  • hematopoietic stem cell
  • epstein barr virus
  • cell therapy
  • bone marrow
  • stem cells
  • emergency department
  • adverse drug
  • smoking cessation
  • electronic health record